Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Trial record 4 of 35 for:    mitraclip

The Influence of MitraClip on Apnoea Asleep (MiClAS)

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
RWTH Aachen University Identifier:
First received: November 19, 2015
Last updated: June 9, 2016
Last verified: November 2015
The aim of the present study is to influence the central and obstructive sleep apnoea in patients with severe mitral insufficiency by an interventional MitraClip examination to evaluate.

Condition Intervention
Sleep Apnoea
Other: MitraClip Intervention

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: the Influence of MitraClip on Apnoea Asleep

Further study details as provided by RWTH Aachen University:

Primary Outcome Measures:
  • Apnoea-Hypopnoea-Index [ Time Frame: 12 months ]

Estimated Enrollment: 34
Study Start Date: November 2015
Estimated Study Completion Date: November 2016
Estimated Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
MitraClip Intervention
the influence of MitraClip on Apnoea Asleep
Other: MitraClip Intervention


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
male and female patients is planned an interventional MitraClip examination

Inclusion Criteria:

  • patient suffer on severe symptomatical mitral insufficience
  • male and female patients is planned an interventional MitraClip examination
  • Dyspnea with a NYHA (New York Heart Association) II - III
  • an high logistic Euro-Score (> 20)
  • no execution of surgical intervention because of relevant comorbidities

Exclusion Criteria:

  • younger than 18 years
  • pregnancy and breast-feeding
  • persons without mental ability of capacity to understand and follow the instructions of the investigator
  • persons in dependence from the sponsor or working with the sponsor
  • participation in other studies
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT02615431

University Hospital RWTH Aachen, Department of Medical Clinic I
Aachen, 52074, Germany
Sponsors and Collaborators
RWTH Aachen University
Principal Investigator: Michael Dreher, MD Uniklinik RWTH Aachen, Med. Klinik I
  More Information

Responsible Party: RWTH Aachen University Identifier: NCT02615431     History of Changes
Other Study ID Numbers: 15-060
Study First Received: November 19, 2015
Last Updated: June 9, 2016

Additional relevant MeSH terms:
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms processed this record on May 23, 2017